unknown
Stage
2
Investors
About
Developer of a precision therapy designed to treat autoimmune disease by targeting the underlying biological drivers of autoimmunity.
Explore Dirigent Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.